Product Description: Atovaquone-d4 is the deuterium labeled Atovaquone. Atovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia[1].
Applications: COVID-19-immunoregulation
Formula: C22H15D4ClO3
References: [1]Looareesuwan, S., et al., Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg, 1996. 54(1): p. 62-6.
CAS Number: 2070015-14-2
Molecular Weight: 370.86
Compound Purity: 99.8
Research Area: Infection
Solubility: 10 mM in DMSO
Target: Isotope-Labeled Compounds;Parasite